Scpharmaceuticals Valuation
| SCPHDelisted Stock | USD 5.67 0.01 0.18% |
At this time, the company appears to be overvalued. Scpharmaceuticals has a current Real Value of $4.58 per share. The regular price of the company is $5.67. Our model measures the value of Scpharmaceuticals from inspecting the company fundamentals such as Shares Outstanding of 53.68 M, return on equity of -9.34, and Operating Margin of (0.89) % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Scpharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Scpharmaceuticals is based on 3 months time horizon. Increasing Scpharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Scpharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Scpharmaceuticals Stock. However, Scpharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5.67 | Real 4.58 | Hype 5.67 | Naive 5.98 |
The intrinsic value of Scpharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Scpharmaceuticals' stock price.
Estimating the potential upside or downside of Scpharmaceuticals helps investors to forecast how Scpharmaceuticals stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Scpharmaceuticals more accurately as focusing exclusively on Scpharmaceuticals' fundamentals will not take into account other important factors: About Scpharmaceuticals Valuation
An absolute valuation paradigm, as applied to Scpharmaceuticals Stock, attempts to find the value of Scpharmaceuticals based on its fundamental and basic technical indicators. By analyzing Scpharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Scpharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Scpharmaceuticals. We calculate exposure to Scpharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Scpharmaceuticals's related companies.scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company has a development agreement with West Pharmaceutical Services, Inc. for development of single use SmartDose device. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts. SC Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Scpharmaceuticals Stock
If you are still planning to invest in Scpharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Scpharmaceuticals' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |